(19)
(11) EP 2 155 678 A1

(12)

(43) Date of publication:
24.02.2010 Bulletin 2010/08

(21) Application number: 08736022.8

(22) Date of filing: 09.04.2008
(51) International Patent Classification (IPC): 
C07D 211/58(2006.01)
C07D 401/12(2006.01)
C07D 409/14(2006.01)
A61K 31/4523(2006.01)
C07D 211/96(2006.01)
C07D 409/12(2006.01)
C07D 413/12(2006.01)
A61P 29/00(2006.01)
(86) International application number:
PCT/EP2008/054298
(87) International publication number:
WO 2008/125570 (23.10.2008 Gazette 2008/43)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 12.04.2007 EP 07106014

(71) Applicant: EVOTEC Neurosciences GmbH
22525 Hamburg (DE)

(72) Inventors:
  • MADDEN, James
    Wokingham RG41 5HX (GB)
  • HALLETT, David
    Marlow SL7 3QY (GB)
  • TAYLOR, Steven
    Didcot OX11 7AU (GB)
  • RAJU, Gurubaran
    Shirley B90 3LZ (GB)
  • WANG, Xiaolu
    22457 Hamburg (DE)
  • GEMKOW, Mark
    22457 Hamburg (DE)

(74) Representative: Büchel, Edwin 
Isenbruck Bösl Hörschler Wichmann LLP Eastsite One Seckenheimer Landstrasse 4
68163 Mannheim
68163 Mannheim (DE)

   


(54) NEW BRADYKININ B1 ANTAGONISTS